Market size — the missing commercial layer

Curated 2026-09-30 by agent research (public web), extended same day with a second retrieval pass. Not generated — each figure was hand-sourced and must be re-verified before commercial use. Scope: the top 20 articles by regulatory pressure (bans/withdrawals/authority mentions weighted 3:2:1), as ranked from the article texts.

Purpose: answer “what is the prize?” for each substitution — the incumbent chemical’s market (what is being replaced) and the bio-alternative’s market (where the agency plays).

Headline finding#

Public market-size data for these niches is thin, and where it exists it often diverges by an order of magnitude between vendors. Fipronil estimates span USD 0.3–2.5 bn (8×) for overlapping years; bioethanol USD 11–91 bn (8×); fish oil USD 1.8–3.4 bn (2×); mycotoxin binders USD 195–454 M. After a second retrieval pass, 6 of the top 20 substitutions still have no usable public figure (feed probiotics specifically, wood preservatives, natural/feed antioxidants, triclosan, malachite green, MTBE). Part of that is the search engine returning irrelevant results for those queries — a retrieval failure, not proof that no market exists.

Two consequences:

1. Market sizing cannot be completed for free. The residue needs either paid report access (Grand View, Mordor, MarketsandMarkets full editions) or bottom-up estimation from production and trade volumes — the vault’s OSINT pipeline cannot produce it.
2. Divergence is itself information. Where vendors disagree 8×, the definition (technical vs formulation, fuel-grade vs value chain, feed vs food) — not the number — is what a serious pitch must pin down.

Summary — top 20 by regulatory pressure#

Filled: 7 · Partial: 3 · Umbrella (covered by A16): 2 · Flagged: 1 · Context: 1 · Gap: 6.

Detail, with sources#

All figures retrieved 2026-09-30 from public web search snippets of the named vendors. These are the vendors’ own headline numbers, not independently verified, and snippet-level citations may not reflect each report’s exact scope.

FI06 — microalgal omega-3 instead of fish and krill oil#

• Incumbent — fish oil: USD 3.4 bn (2025, Fortune Business Insights, fortunebusinessinsights.com/industry-reports/fish-oil-market-100741) vs USD 1.8 bn (2025, Future Market Insights) — 2× spread, definitional.
• Incumbent — EPA+DHA ingredients (the tighter scope): USD 2.353 bn (2025, GOED Ingredient Market Report, goedomega3.com) — trade-body figure, the most credible of the three.
• Context: omega-3 supplements overall USD 7.7 bn (2024, Grand View Research).
• Alternative — algae-derived DHA: USD 1.8 bn (2025) → USD 4.2 bn (2034), CAGR 9.8 % (DataIntelo).
• Volume anchor: global algal omega-3 oil production 5,633 t (2024, GOED via Naturmega).
• Read: the alternative is already ~76 % the size of the whole EPA+DHA ingredient market on a value basis — growth here is substitution, not expansion.

V01 / V02 — probiotics and organic acids instead of antibiotic growth promoters, ZnO and colistin#

• Alternative — feed acidifiers: USD 2.2 bn (2023, GM Insights) / USD 2.87 bn (2026, Mordor Intelligence, CAGR 5.43 %) / USD 3.75 bn (2024, SkyQuest) / USD 2.7 → 3.5 bn (2018–2023, MarketsandMarkets). Cluster USD 2.2–3.8 bn, CAGR ~5–6 %.
• Alternative — feed probiotics specifically: no reliable figure retrieved — every query returned irrelevant results. The acidifiers figure is the closest proxy for the same ration slot.
• Incumbent — AGPs, pharmacological ZnO, colistin: no meaningful “market” figure, and that is the correct answer rather than a gap: the substances are banned or withdrawn in the jurisdictions driving demand (EU AGP ban 2006, ZnO withdrawal 2022–23, colistin restrictions). The prize is the replacement share of the feed-additive sector, not an incumbent market that persists.
• Read: this is the strongest structural substitution in the vault — demand is created by law, and the replacement category already turns over USD 2–4 bn.

A16 — integrated biocontrol instead of mancozeb/chlorothalonil (umbrella for A01, A05, A13, A23)#

• Incumbent — mancozeb: USD 1.15 bn (2022, Insight Partners) / USD 1.16 bn (2024, DataBridge) / USD 1.78 bn (2023, Zion) — cluster around 1.0–1.8 bn.
• Alternative — biopesticides: USD 7.89 bn (2024, MarkNtel) / USD 7.98 bn (2024, BusinessWire summary) / USD 8.94 bn (2025, Verified Market Reports), growing 14–15 % CAGR to USD 18–23 bn by 2030–32.
• Read: the alternative market is already ~7× the incumbent on these definitions. The agency’s play is not category creation; it is share capture in a fast-compounding category where the specific article gaps (A12, A06–A09) still have no supplier in our index.

V11 — mycotoxin detoxifiers instead of clay-only binders#

• Incumbent — mycotoxin binders: USD 195.5 M (2024, GII Research) vs USD 454 M (2025, 360iResearch) — 2.3× spread.
• Regional: Africa feed mycotoxin detoxifiers USD 118 M (2026, Mordor Intelligence) — directly relevant to our Africa & ME dataset.
• Alternative (enzyme detoxifiers): no reliable public figure found.
• Read: small incumbent market, but the Africa figure gives a concrete regional prize for a vault whose largest dataset is Africa & ME.

F07 — phage/probiotics instead of antibiotics in aquaculture#

• Alternative — aquaculture vaccines: autogenous vaccines USD 2.98 bn (2025, ReportCubes); Japan USD 22.8 M (2025, FMI); North America ~USD 25 M (older, Aquaculture North America). The autogenous figure is much larger than the regional splits, suggesting a broad or different definition — verify before use.
• Incumbent — aquaculture antibiotics: no reliable public figure found.
• Read: vaccines are the proven substitution route (Norway’s >99 % antibiotic reduction is in the article); phage specifically has no market figure at all, which matches our finding that no index supplier qualifies for F07.

E08 — biological slug control instead of metaldehyde#

• Incumbent — molluscicides: USD 711 M → 909 M by 2026, CAGR 8.5 % (MarketsandMarkets figure as cited in a secondary source; provenance weaker than the others here).
• Alternative: no reliable public figure for biological slug control.

V08 — predatory mites/silica instead of fipronil (poultry red mite)#

• Incumbent — fipronil: USD 306.7 M (2025, Grand View, fipronil pyrazole) / USD 426 M (2026, Coherent) / USD 482.6 M (2024, Custom Market Insights) / USD 954.8 M (2026, Market Growth Reports) / USD 2.5 bn (2025, Straits) — an 8× spread across five vendors.
• Alternative: within biocontrol (see A16); no poultry-red-mite-specific figure.
• Read: treat the fipronil “market” as undefined until scope is fixed (technical-grade vs formulated, crop vs public health vs animal health). This is the clearest example of why headline market numbers cannot be used in a pitch without reading the definition.

C02 — bio-based insulation instead of HBCDD-flame-retarded foams#

• Alternative — wood-fibre insulation: USD 958.3 M (2025) → USD 1,785 M (2035) (SNS Insider). The cleanest bio-based-insulation figure found.
• Context — building insulation overall: USD 15.1 bn commercial (2025, via Yahoo Finance summary) to USD 16.7 bn acoustic (2025, Strategic Market Research) — scope differs; treat as ordering only.
• Incumbent — flame-retardant chemicals: no reliable figure retrieved (queries returned irrelevant results).
• Read: wood-fibre is roughly a 1 bn slice inside a 15 bn+ envelope — the substitution prize is the halogenated-foam share of that envelope, which no public source separates out.

EN02 — bioethanol instead of MTBE and aromatics#

• Alternative — bioethanol: USD 11.36 bn (2025, IMARC) / USD 59.14 bn (2026, The Business Research Company) / USD 91.38 bn (2026, Research Nester) — an 8× spread, almost certainly definitional (fuel-grade ethanol transaction value vs the whole bioethanol value chain).
• Volume anchor: 124.07 bn litres (2026, Mordor Intelligence, CAGR 5.08 %); US production ~15 bn gal/yr (Growth Energy).
• Incumbent — MTBE: no reliable figure retrieved.
• Read: use the volume anchor, not the value spread — litres are comparable across sources and dollars are not.

P05 — ethylene instead of calcium carbide (recorded as context, not a prize)#

• Context — ethylene commodity market: USD 166.5 bn (2019, Fortune Business Insights) to ~USD 198 bn (2024, Market Research Future).
• Why this is not the article’s market: fruit ripening consumes a negligible slice of ethylene; no public source separates a “ripening-agent” segment. Recording the commodity number as the prize would overstate it by orders of magnitude. The honest position: no usable figure; the driver is the calcium-carbide ban in ripening, not the ethylene market.

PK03 — biodegradable mulch film instead of PE#

• One public claim: “global biodegradable mulch films market USD 52.8 bn (2022), CAGR 9.5 %” (Spherical Insights).
• Flagged as implausible: the conventional mulch-film market (all materials) is cited an order of magnitude lower; USD 52.8 bn likely a scope or unit error in the vendor’s summary. Do not use.
• No reliable alternative figure found.

What to do about the six remaining gaps#

Ranked by feasibility:

1. Paid report access to two or three full editions (Grand View / Mordor / MarketsandMarkets) would close the materials and additive gaps (E11 wood preservatives, FI03/F06 antioxidants, E10 triclosan, P04 sanitation). Cost: report licences, not API spend.
2. Bottom-up sizing from volumes is possible from public trade data for the commodity incumbents (MTBE, phthalates, calcium carbide) where market value follows volume × price.
3. Leave the niche chemicals unsized (malachite green, ethoxyquin) — these markets are small and opaque by nature, and an honest “prize unknown, driver is regulatory” is more useful than a fabricated number.
4. Re-run the retrieval on another day. Several failures looked like search-engine noise rather than absence of data (the same query for feed acidifiers succeeded while feed probiotics returned junk), so a second pass may fill two or three rows for free.

Method and limits#

• Ranking: regulatory-pressure score = 3×(ban/withdraw/phase-out terms) + 2×(named authorities) + 1×(registration terms) per article, computed over all 121 articles on 2026-09-30.
• Figures are vendor headline numbers from public search snippets, not the underlying reports; scopes differ between vendors and are frequently the cause of the spread.
• Two retrieval passes were run on 2026-09-30; queries that returned irrelevant results are recorded as gaps, not as zero.
• No figure here has been checked against a full report. Before any commercial use, buy or borrow the cited report and read its definition section.
• Nothing in this file has been written into the article files; merge only after review.